Báo cáo khoa học: "Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies"

Báo cáo khoa học: "Drotrecogin alfa (activated): down and not out, but not really in eithe"

2 p | 63 | 7

Báo cáo y học: "Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification Pierre-François Laterre and Xavier Wittebole"

6 p | 57 | 6

Báo cáo y học: " The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes"

14 p | 43 | 5

Báo cáo y học: "Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis"

9 p | 57 | 5

Báo cáo khoa học: "Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death"

2 p | 57 | 5

Báo cáo khoa học: "Timing of drotrecogin alfa (activated) treatment in severe sepsis"

2 p | 51 | 4

Báo cáo y học: "Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy"

6 p | 79 | 4

Báo cáo y học: "Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock"

6 p | 51 | 4

Báo cáo khoa học: "Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis"

2 p | 35 | 3